Anti-Obesity Medications
Modern, Science-Backed Solutions for Weight Management
Achieve Lasting Weight Loss with Anti-obesity Medications (AOM)
We provide expert guidance and personalized treatment plans that integrate cutting-edge medications, ensuring optimal and sustainable results.
Certain medications, such as glucagon-like peptide-1 receptor agonists (GLP-1 RA), have demonstrated their ability to help patients lose up to 15% or more of their body weight when used consistently and correctly. However, their long-term use is essential for maintaining effectiveness and maximizing results.
Why Choose Anti-obesity Medications?
Personalized Consultation & Treatment Plan
We will assess your candidacy for anti-obesity medications (AOM) therapy and discuss how we can enhance your results with safe, effective, and minimally invasive endoscopic procedures, such as ESG + WL® (endoscopic sleeve gastroplasty with weight-loss therapy).
Who Qualifies for Anti-obesity Medications?
- Metabolic dysfunction-associated steatotic liver disease (MASLD)
- Sleep apnea
- Hypertension, high cholesterol, or type 2 diabetes
- Osteoarthritis
Your journey to a healthier, happier you starts today
Know more about anti-obesity medications (AOM)
Frequently asked questions
1. Will my insurance cover anti-obesity medications (AOM)?
Coverage depends on individual insurance policies and the presence of certain medical conditions.
2. What sort of follow-up will I have?
We take pride in the follow-up care we provide to our patients at IMCEB and BEM. We believe that the most important aspect of our job extends beyond your procedure with us; rather, we aim to be a key partner in your journey to well-being.
Our well-established and internationally recognized follow-up program and care team set us apart, and you will have scheduled visits over the course of a year.
3. What happens to my weight after stopping anti-obesity medications (AOM)?
Although one of our goals is to help you develop healthy habits that encourage weight loss and overall well-being, you may gain weight after stopping anti-obesity medications (AOM).
Recent studies indicate that around 20% of patients discontinue the medication due to intolerance, and once they stop taking it, they often regain up to two-thirds of the weight lost within a year.
4. How do anti-obesity medications (AOM) compare to endoscopic sleeve gastroplasty (ESG +WL®)?
Although both interventions are safe and effective tools for weight loss and treating metabolic diseases, recent studies have indicated that endoscopic sleeve gastroplasty (ESG +WL®) results in more significant and sustainable weight loss over a five-year period and is more cost-effective in the long term compared to anti-obesity medications (AOM).
At IMCEB and BEM, we will assist you in selecting and personalizing the best therapy to achieve a healthier weight and enhance your well-being.
5. Why should I choose IMCEB (Instituto Mexicano de Cirugía Endoscópica y Bariátrica) and Bariatric Endoscopy of Mexico (BEM) for my procedure?
Dr. Sánchez-Luna is a trailblazer in bariatric, metabolic, and surgical endoscopy in Mexico. He is the Founder and CEO of both IMCEB and BEM, and the only physician in Mexico and Latin America triple-board certified in Internal Medicine, Gastroenterology, and Obesity Medicine by U.S. boards. He also holds full medical licensure in Mexico to practice Medicine, Gastroenterology, and Interventional Endoscopy.
With a career dedicated to transformative care, Dr. Sánchez-Luna has successfully treated over 11,000 patients. Since 2019, he has led six advanced training courses in endoscopic suturing using the OverStitch™ Endoscopic Suturing System—the same cutting-edge device he uses in his procedures. With nearly a decade of hands-on experience, he is Mexico’s most experienced operator of the OverStitch™ system, setting the standard for excellence in endoscopic weight loss solutions.